Wehn AK, Qiu P, Lunceford J, Yarunin A, et al. Concordance between an FDA-approved companion diagnostic and an alternative assay kit for assessing homologous recombination deficiency in ovarian cancer. Gynecol Oncol 2024;184:67-73.
PMID: 38290412